We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for real-time alerts, custom portfolio, and market movers
The current CRDL market cap is 101.19M. The company's latest EPS is CAD -0.3447 and P/E is -5.22.
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| CAD ($) | CAD ($) | CAD ($) | CAD ($) | CAD ($) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -7.66M | -11.17M | -8.41M | -7.74M | -14.14M |
| Net Income | -5.93M | -7.64M | -9.18M | -6.59M | -12.73M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| CAD ($) | CAD ($) | CAD ($) | CAD ($) | CAD ($) | |
| Total Revenue | 0 | 7k | 79k | 0 | 0 |
| Operating Income | -14.13M | -20.68M | -38.66M | -41.34M | -29.79M |
| Net Income | -13.68M | -20.64M | -31.64M | -30.93M | -28.13M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| CAD ($) | CAD ($) | CAD ($) | CAD ($) | CAD ($) | |
| Total Assets | 43.05M | 36.7M | 31.13M | 26.31M | 17.52M |
| Total Liabilities | 8.18M | 8.45M | 11.07M | 10.95M | 7.09M |
| Total Equity | 34.87M | 28.25M | 20.06M | 15.36M | 10.43M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| CAD ($) | CAD ($) | CAD ($) | CAD ($) | CAD ($) | |
| Total Assets | 15.5M | 15.89M | 87.88M | 62.03M | 36.7M |
| Total Liabilities | 831k | 2.62M | 11.64M | 9.83M | 8.45M |
| Total Equity | 14.67M | 13.27M | 76.24M | 52.2M | 28.25M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| CAD ($) | CAD ($) | CAD ($) | CAD ($) | CAD ($) | |
| Operating | -18.72M | -25.18M | -6.92M | -11.7M | -19.47M |
| Investing | -54k | -64k | -3k | -7k | -15k |
| Financing | -41k | -55k | 76k | 155k | 150k |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| CAD ($) | CAD ($) | CAD ($) | CAD ($) | CAD ($) | |
| Operating | -11.38M | -9.19M | -23.55M | -27.22M | -25.18M |
| Investing | -424k | -41k | -13k | -75k | -64k |
| Financing | 2.03M | 16.3M | 93.44M | -54k | -55k |
| Market Cap | 101.19M |
| Price to Earnings Ratio | -5.22 |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 4.2 |
| Price to Book Ratio | 5.2 |
| Dividend Yield | - |
| Shares Outstanding | 81.6M |
| Average Volume (1 week) | 399.47k |
| Average Volume (1 Month) | 392.65k |
| 52 Week Change | 51.70% |
| 52 Week High | 3.12 |
| 52 Week Low | 0.8174 |
| Spread (Intraday) | 0.01 (0.8%) |
| Company Name | Cardiol Therapeutics Inc |
| Address |
2265 upper middle road east oakville, ontario L6H 0C3 |
| Website | https:// |
| Industry | coml physical, biologcl resh (8731) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
